Patents by Inventor Michael W. Draper

Michael W. Draper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical unit dosage formulations
    Patent number: 5747510
    Abstract: A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: May 5, 1998
    Assignee: Eli Lilly and Company
    Inventor: Michael W. Draper
  • Methods for inhibiting endometriosis
    Patent number: 5693656
    Abstract: A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: December 2, 1997
    Assignee: Eli Lilly and Company
    Inventors: Larry J. Black, George J. Cullinan, Michael W. Draper, Charles D. Jones, David E. Seyler
  • Methods of use for inhibiting bone loss and lowering serum cholesterol
    Patent number: 5641790
    Abstract: A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: June 24, 1997
    Assignee: Eli Lilly and Company
    Inventor: Michael W. Draper
  • Methods of use for inhibiting bone loss and lowering serum cholesterol
    Patent number: 5610168
    Abstract: A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: March 11, 1997
    Assignee: Eli Lilly and Company
    Inventor: Michael W. Draper
  • Methods of use for inhibiting bone loss and lowering serum cholesterol
    Patent number: 5478847
    Abstract: A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
    Type: Grant
    Filed: March 2, 1994
    Date of Patent: December 26, 1995
    Assignee: Eli Lilly and Company
    Inventor: Michael W. Draper
  • Methods for inhibiting endometriosis
    Patent number: 5461065
    Abstract: A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl;R.sup.2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: October 24, 1995
    Assignee: Eli Lilly and Company
    Inventors: Larry J. Black, George J. Cullinan, Michael W. Draper, Charles D. Jones, David E. Seyler
  • Methods of inhibiting uterine fibrosis
    Patent number: 5457116
    Abstract: A method of inhibiting uterine fibrosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R.sup.1 and R.sup.3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; wherein R.sup.2 is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: October 10, 1995
    Assignee: Eli Lilly and Company
    Inventors: Larry J. Black, George J. Cullinan, Michael W. Draper, Charles D. Jones, David E. Seyler
  • Methods of use for inhibiting bone loss and lowering serum cholesterol
    Patent number: RE39050
    Abstract: A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompassed by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: March 28, 2006
    Assignee: Eli Lilly and Company
    Inventors: Michael W. Draper, Larry J. Black